It has also been found that Krüppel-like factor 11(KLF11) suppressed the progression of ccRCC by increasing the transcription of nuclear receptor coactivator 4 (NCOA4), which may be a therapeutic target for ccRCC [11]. This evidence concerns the gene NCOA4 and nonpapillary renal cell carcinoma.